HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rui Chen Selected Research

Vitreoretinochoroidopathy

1/2021Variable expressivity of BEST1-associated autosomal dominant vitreoretinochoroidopathy (ADVIRC) in a three-generation pedigree.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rui Chen Research Topics

Disease

236Neoplasms (Cancer)
05/2022 - 01/2005
65Inflammation (Inflammations)
01/2022 - 04/2003
42Neoplasm Metastasis (Metastasis)
04/2022 - 09/2008
38Infections
11/2022 - 08/2008
37Breast Neoplasms (Breast Cancer)
05/2022 - 03/2005
32Hypoxia (Hypoxemia)
01/2022 - 06/2003
31Carcinogenesis
04/2022 - 04/2006
31Prostatic Neoplasms (Prostate Cancer)
05/2021 - 09/2008
27Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 05/2011
27Hepatocellular Carcinoma (Hepatoma)
12/2021 - 04/2008
22Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 11/2006
21Stomach Neoplasms (Stomach Cancer)
04/2022 - 06/2007
21Obesity
03/2022 - 10/2008
20Body Weight (Weight, Body)
12/2021 - 09/2008
18Wounds and Injuries (Trauma)
11/2022 - 11/2010
16Insulin Resistance
12/2020 - 12/2006
15Fibrosis (Cirrhosis)
01/2022 - 01/2002
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 01/2014
13Sepsis (Septicemia)
06/2022 - 01/2014
13Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 04/2011
13Glioma (Gliomas)
01/2022 - 11/2013
13Obstructive Sleep Apnea
01/2022 - 01/2012
13Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 04/2006
13Carcinoma (Carcinomatosis)
01/2021 - 10/2005
12Atherosclerosis
01/2022 - 11/2004
12Retinal Diseases
01/2022 - 01/2013
11Virus Diseases (Viral Diseases)
01/2022 - 11/2009
11Lung Neoplasms (Lung Cancer)
07/2021 - 12/2012
10Necrosis
10/2022 - 08/2012
10Type 2 Diabetes Mellitus (MODY)
10/2022 - 05/2010
10Cognitive Dysfunction
04/2022 - 04/2008
10Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 03/2009
10Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2019 - 01/2012
9Neurodegenerative Diseases (Neurodegenerative Disease)
05/2022 - 03/2009
9Adenocarcinoma of Lung
04/2022 - 11/2014
9Atrophy
04/2022 - 09/2008
9Squamous Cell Carcinoma of Head and Neck
03/2022 - 06/2012
9Hypertension (High Blood Pressure)
03/2022 - 11/2008
9Glioblastoma (Glioblastoma Multiforme)
01/2022 - 11/2010
9Brain Ischemia (Cerebral Ischemia)
01/2022 - 08/2004
9Asthma (Bronchial Asthma)
01/2022 - 08/2005
8Alzheimer Disease (Alzheimer's Disease)
12/2022 - 01/2016
8Parkinson Disease (Parkinson's Disease)
05/2022 - 09/2013
8Pain (Aches)
01/2022 - 01/2017
8Heart Failure
12/2020 - 10/2004
7Stroke (Strokes)
11/2022 - 11/2006
7Muscular Atrophy (Muscle Atrophy)
06/2022 - 11/2019
7Thrombosis (Thrombus)
01/2022 - 12/2011
7Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2016
7Pneumonia (Pneumonitis)
01/2021 - 03/2013

Drug/Important Bio-Agent (IBA)

101Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2004
40Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2007
38MicroRNAs (MicroRNA)IBA
02/2022 - 11/2009
37Pharmaceutical PreparationsIBA
10/2022 - 10/2005
37Messenger RNA (mRNA)IBA
01/2022 - 10/2005
36Long Noncoding RNAIBA
09/2022 - 11/2014
33Biological ProductsIBA
01/2022 - 08/2007
31CytokinesIBA
03/2022 - 10/2004
25RNA (Ribonucleic Acid)IBA
03/2022 - 08/2009
25Particulate MatterIBA
03/2022 - 01/2016
22Glucose (Dextrose)FDA LinkGeneric
03/2022 - 05/2007
21DNA (Deoxyribonucleic Acid)IBA
09/2021 - 08/2002
18Retinaldehyde (Retinal)IBA
04/2022 - 01/2013
17LipidsIBA
09/2022 - 11/2004
16Sirtuin 1IBA
12/2021 - 03/2009
16Peptides (Polypeptides)IBA
01/2021 - 01/2006
15Oxygen (Dioxygen)IBA
01/2021 - 01/2005
14Indicators and Reagents (Reagents)IBA
03/2022 - 11/2008
14Small Interfering RNA (siRNA)IBA
01/2022 - 12/2012
14Transcription Factors (Transcription Factor)IBA
10/2020 - 06/2009
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022 - 10/2004
12Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2004
12EnzymesIBA
12/2020 - 02/2011
11LigandsIBA
12/2022 - 02/2007
11Angiotensin IIIBA
07/2022 - 10/2003
11Therapeutic UsesIBA
06/2022 - 12/2014
11NF-kappa B (NF-kB)IBA
10/2021 - 02/2007
10Insulin (Novolin)FDA Link
10/2022 - 05/2007
10Cisplatin (Platino)FDA LinkGeneric
03/2022 - 10/2005
10CholesterolIBA
01/2022 - 11/2004
9AntigensIBA
01/2022 - 07/2009
9Prostate-Specific Antigen (Semenogelase)IBA
05/2021 - 01/2013
8Apolipoproteins E (ApoE)IBA
09/2022 - 09/2005
8oxidized low density lipoproteinIBA
01/2022 - 01/2012
8Competitive Endogenous RNAIBA
12/2021 - 11/2019
8Protein Isoforms (Isoforms)IBA
06/2021 - 04/2010
8C-Reactive ProteinIBA
05/2021 - 12/2009
7Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2022 - 11/2008
7Circular RNAIBA
01/2022 - 10/2016
7LipopolysaccharidesIBA
01/2022 - 04/2006
7CollagenIBA
12/2020 - 02/2005

Therapy/Procedure

100Therapeutics
07/2022 - 01/2006
33Drug Therapy (Chemotherapy)
07/2022 - 12/2006
14Immunotherapy
05/2022 - 08/2010
12Electroacupuncture
01/2022 - 01/2011
11Neoadjuvant Therapy
05/2022 - 07/2018
10Lasers (Laser)
01/2022 - 12/2006
8Ligation
06/2022 - 09/2006
7Aftercare (After-Treatment)
11/2022 - 11/2008
7Precision Medicine
01/2022 - 02/2013